Literature DB >> 12659062

Two cases of rhabdomyolysis associated with high-dose simvastatin.

Maryann Z Skrabal1, Julie A Stading, Carrie A Cannella, Michael S Monaghan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12659062     DOI： 10.1093/ajhp/60.6.578

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

1.  A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.

Authors:  Dominic Mitchell; Jason R Guertin; Anick Dubois; Marie-Pierre Dubé; Jean-Claude Tardif; Ange Christelle Iliza; Fiorella Fanton-Aita; Alexis Matteau; Jacques LeLorier
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

2.  The Potential Return on Public Investment in Detecting Adverse Drug Effects.

Authors:  Krista F Huybrechts; Rishi J Desai; Moa Park; Joshua J Gagne; Mehdi Najafzadeh; Jerry Avorn
Journal:  Med Care       Date:  2017-06       Impact factor: 2.983

3.  Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk.

Authors:  Jon Conly; Fiona Clement; Marcello Tonelli; Brenda Hemmelgarn; Scott Klarenbach; Anita Lloyd; Finlay A McAlister; Don Husereau; Natasha Wiebe; Flora Au; Braden Manns
Journal:  CMAJ       Date:  2011-10-11       Impact factor: 8.262

4.  Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction.

Authors:  Johanna Strandell; Andrew Bate; Staffan Hägg; I Ralph Edwards
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.